524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹42
- High
- ₹46
- 52 Week Low
- ₹27
- 52 Week High
- ₹48
- Open Price₹46
- Previous Close₹44
- Volume5,204
- 50 DMA₹38.56
- 100 DMA₹38.76
- 200 DMA₹37.77
Investment Returns
- Over 1 Month + 10.35%
- Over 3 Month + 4.12%
- Over 6 Month + 20.06%
- Over 1 Year -1.33%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 96.9
- PEG Ratio
- 1.5
- Market Cap Cr
- 62
- P/B Ratio
- 2.3
- Average True Range
- 3.14
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.7
- RSI
- 64.63
- MFI
- 85.43
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹42.98
-0.68
(-1.56%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹39.53
- 50 Day
- ₹38.56
- 100 Day
- ₹38.76
- 200 Day
- ₹37.77
Resistance and Support
42.47
- R3 48.68
- R2 46.21
- R1 44.94
- S1 41.20
- S2 38.73
- S3 37.46
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹42 As on 16 January, 2026 | 12:02
The Market Cap of Bacil Pharma is ₹61.7 Cr As on 16 January, 2026 | 12:02
The P/E ratio of Bacil Pharma is 96.9 As on 16 January, 2026 | 12:02
The PB ratio of Bacil Pharma is 2.3 As on 16 January, 2026 | 12:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.